NEW YORK ─ An international group of researchers has reported promising results for a portable flow-cytometry test that they are developing to enable breast cancer diagnosis and subtyping in one day.
The point-of-care test has the potential to address a critical unmet medical need, according to its developers ─ that of quickly ruling in or ruling out breast cancer in settings where hospital laboratories are not available.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
